Carrie Pistenmaa Aaron

Carrie Pistenmaa Aaron

Auto-generated profile, based on publicly available information

Carrie Pistenmaa Aaron

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2019 in JAMA
Verified
Journal Article
Open access
PDF file
MWMeng Wang
Meng Wang
CACarrie Pistenmaa Aaron
Carrie Pistenmaa Aaron
JMJaime Madrigano
Jaime Madrigano
EHEric A. Hoffman
Eric A. Hoffman
EAElsa Angelini
Elsa Angelini
RBR. Graham Barr
R. Graham Barr
Quiz Ref ID Chronic lower respiratory disease is the fourth leading cause of death in the United States and third leading cause of death worldwide.1,2 Most of this mortality is due to chronic obstructive pulmonary disease (COPD), defined by persistent airflow limitation, measured via spirometry, and pulmonary emphysema, defined by destruction of the lung parenchyma.3 Quiz Ref ID Emphysema can be measured quantitatively on computed tomographic (CT) imaging and can be observed without spirometric COPD.4,5 The percentage of emphysema-like lung on CT scans (“percent emphysema”) is associated with the degree of lung function impairment and symptoms as well as mortality in patients with COPD.6 Percent emphysema is also associated with dyspnea and disease exacerbations independent of lung function among smokers7 and with incident COPD and all-cause mortality among individuals without COPD in the general population.4,8

15 August 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
GWGeorge R. Washko
George R. Washko
PNPietro Nardelli
Pietro Nardelli
SASamuel Y. Ash
Samuel Y. Ash
GSGonzalo Vegas Sanchez-Ferrero
Gonzalo Vegas Sanchez-Ferrero
FRFarbod N. Rahaghi
Farbod N. Rahaghi
RERaúl San José Estépar
Raúl San José Estépar
Rationale: Cor pulmonale (right ventricular [RV] dilation) and cor pulmonale parvus (RV shrinkage) are both described in chronic obstructive pulmonary disease (COPD). The identification of emphysema as a shared risk factor suggests that additional disease characterization is needed to understand these widely divergent cardiac processes. Objectives: To explore the relationship between computed tomography measures of emphysema and distal pulmonary arterial morphology with RV volume, and their association with exercise capacity and mortality in ever-smokers with COPD enrolled in the COPDGene Study. Methods: Epicardial (myocardium and chamber) RV volume (RVEV), distal pulmonary arterial blood vessel volume (arterial BV5: vessels <5 mm2 in cross-section), and objective measures of emphysema were extracted from 3,506 COPDGene computed tomography scans. Multivariable linear and Cox regression models and the log-rank test were used to explore the association between emphysema, arterial BV5, and RVEV with exercise capacity (6-min-walk distance) and all-cause mortality. Measurements and Main Results: The RVEV was approximately 10% smaller in Global Initiative for Chronic Obstructive Lung Disease stage 4 versus stage 1 COPD (P < 0.0001). In multivariable modeling, a 10-ml decrease in arterial BV5 (pruning) was associated with a 1-ml increase in RVEV. For a given amount of emphysema, relative preservation of the arterial BV5 was associated with a smaller RVEV. An increased RVEV was associated with reduced 6-minute-walk distance and in those with arterial pruning an increased mortality. Conclusions: Pulmonary arterial pruning is associated with clinically significant increases in RV volume in smokers with COPD and is related to exercise capacity and mortality in COPD. Clinical trial registered with www.clinicaltrials.gov (NCT 00608764).

1 March 2019 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
MBMartha E. Billings
Martha E. Billings
DGDiane Gold
Diane Gold
ASAdam Szpiro
Adam Szpiro
CACarrie P. Aaron
Carrie P. Aaron
NJNeal Jorgensen
Neal Jorgensen
SRSusan R. Redline
Susan R. Redline
Rationale: Air pollution may influence sleep through airway inflammation or autonomic nervous system pathway alterations. Epidemiological studies may provide evidence of relationships between chronic air pollution exposure and sleep apnea. Objectives: To determine whether ambient-derived pollution exposure is associated with obstructive sleep apnea and objective sleep disruption. Methods: We analyzed data from a sample of participants in MESA (Multi-Ethnic Study of Atherosclerosis) who participated in both the Sleep and Air studies. Mean annual and 5-year exposure levels to nitrogen dioxide (NO2) and particulate matter ≤ 2.5 μm in aerodynamic diameter (PM2.5) were estimated at participants’ homes using spatiotemporal models based on cohort-specific monitoring. Participants completed in-home full polysomnography and 7 days of wrist actigraphy. We used multivariate models, adjusted for demographics, comorbidities, socioeconomic factors, and site, to assess whether air pollution was associated with sleep apnea (apnea–hypopnea index ≥ 15) and actigraphy-measured sleep efficiency. Results: The participants (n = 1,974) were an average age of 68 (±9) years, 46% male, 36% white, 24% Hispanic, 28% black, and 12% Asian; 48% had sleep apnea and 25% had a sleep efficiency of ≤88%. A 10 ppb annual increase in NO2 exposure was associated with 39% greater adjusted odds of sleep apnea (95% confidence interval [CI], 1.03–1.87). A 5 μg/m3 greater annual PM2.5 exposure was also associated with 60% greater odds of sleep apnea (95% CI, 0.98–2.62). Sleep efficiency was not associated with air pollution levels in fully adjusted models. Conclusions: Individuals with higher annual NO2 and PM2.5 exposure levels had a greater odds of sleep apnea. These data suggest that in addition to individual risk factors, environmental factors also contribute to the variation of sleep disorders across groups, possibly contributing to health disparities.

1 February 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
CACarrie P. Aaron
Carrie P. Aaron
HTHarikrishna Tandri
Harikrishna Tandri
RBR. Graham Barr
R. Graham Barr
WJW. Craig Johnson
W. Craig Johnson
EBEmilia Bagiella
Emilia Bagiella
SKSteven M. Kawut
Steven M. Kawut
Rationale: Intense exercise in elite athletes is associated with increased left ventricular (LV) and right ventricular (RV) mass and volumes. However, the effect of physical activity on the RV in an older community-based population is unknown. Objectives: We studied the association between levels of physical activity in adults and RV mass and volumes. Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) performed cardiac magnetic resonance imaging on community-based participants without clinical cardiovascular disease. RV volumes were determined from manually contoured endocardial margins. RV mass was determined from the difference between epicardial and endocardial volumes multiplied by the specific gravity of myocardium. Metabolic equivalent–minutes/day were calculated from the self-reported frequency, duration, and intensity of physical activity. Measurements and Main Results: The study sample (n = 1,867) was aged 61.8 ± 10 years, 48% male, 44% white, 27% African American, 20% Hispanic, and 9% Chinese. Higher levels of moderate and vigorous physical activity were linearly associated with higher RV mass (P = 0.02) after adjusting for demographics, anthropometrics, smoking, cholesterol, diabetes mellitus, hypertension, and LV mass. Higher levels of intentional exercise (physical activity done for the sole purpose of conditioning or fitness) were nonlinearly associated with RV mass independent of LV mass (P = 0.03). There were similar associations between higher levels of physical activity and larger RV volumes. Conclusions: Higher levels of physical activity in adults were associated with greater RV mass independent of the associations with LV mass; similar results were found for RV volumes. Exercise-associated RV remodeling may have important clinical implications.

16 February 2021 in Radiology
Verified
Journal Article
Closed access
SASamuel Y. Ash
Samuel Y. Ash
RERaúl San José Estépar
Raúl San José Estépar
SFSean Fain
Sean Fain
RTRuth Tal-Singer
Ruth Tal-Singer
RSRobert A. Stockley
Robert A. Stockley
TCthe COPD Biomarker Qualification Consortium
the COPD Biomarker Qualification Consortium
In participants with emphysema, quantitatively measured emphysema progression at CT was associated with increased mortality. Background The relationship between emphysema progression and long-term outcomes is unclear. Purpose To determine the relationship between emphysema progression at CT and mortality among participan...

20 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CACarrie P. Aaron
Carrie P. Aaron
EHEric A. Hoffman
Eric A. Hoffman
JLJoao A. C. Lima
Joao A. C. Lima
SKSteven M. Kawut
Steven M. Kawut
ABAlain G Gerald Bertoni
Alain G Gerald Bertoni
RBR. Graham Barr
R. Graham Barr
Evaluation of impaired left ventricular (LV) filling has focused on intrinsic causes of LV dysfunction; however, pulmonary vascular changes may contribute to reduced LV filling and dyspnea. We hypothesized that lower total pulmonary vascular volume (TPVV) on computed tomography (CT) would be associated with dyspnea and decrements in LV end-diastolic volume, particularly among ever-smokers. The Multi-Ethnic Study of Atherosclerosis recruited adults without clinical cardiovascular disease in 2000–02. In 2010–12, TPVV was ascertained as the volume of arteries and veins in the lungs detectable on non-contrast chest CT (vessels ≥1 mm diameter). Cardiac measures were assessed by magnetic resonance imaging (MRI). Dyspnea was self-reported. Of 2303 participants, 53% had ever smoked cigarettes. Among ever-smokers, a lower TPVV was associated with a lower LV end-diastolic volume (6.9 mL per SD TPVV), stroke volume, and cardiac output and with dyspnea (all P-values <0.001). Findings were similar among those without lung disease and those with 0–10 pack-years but were mostly non-significant among never-smokers. TPVV was associated smaller left atrial volume but not with LV ejection fraction or MRI measures of impaired LV relaxation. In a second sample of ever-smokers, a lower pulmonary microvascular blood volume on contrast-enhanced MRI was also associated with a lower LV end-diastolic volume (P-value = 0.008). Reductions in pulmonary vascular volume were associated with lower LV filling and dyspnea among ever-smokers, including those without lung disease, suggesting that smoking-related pulmonary vascular changes may contribute to symptoms and impair cardiac filling and function without evidence of impaired LV relaxation.